Anwulignan is a novel JAK1 inhibitor that suppresses non‐small cell lung cancer growth

Anwulignan is a monomer compound derived from Schisandra sphenanthera lignans. It has been reported to possess a spectrum of pharmacological activities, including anti‐bacterial, anti‐inflammatory, anticancer and hepatoprotective properties. However, its anticancer capacity and molecular mechanism(s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaomeng, Wang, Xiangyu, Shi, Xiaodan, Zhang, Yuanyuan, Laster, Kyle Vaughn, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933975/
https://www.ncbi.nlm.nih.gov/pubmed/33523587
http://dx.doi.org/10.1111/jcmm.16289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933975/
https://www.ncbi.nlm.nih.gov/pubmed/33523587
http://dx.doi.org/10.1111/jcmm.16289

Ejemplares similares